http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 12 Jan 2026 08:31:59 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Picard+Medical+partners+with+Hydrix+to+develop+next-gen+artificial+heart/25834966.html <p>Picard Medical Inc. (NYSE American: PMI) announced that its subsidiary SynCardia Systems entered into a development collaboration agreement with Hydrix Services Pty Ltd on January 5, 2026. The partnership aims to advance SynCardia's next-generation total artificial heart technology called the Emperor.</p><p>The Emperor represents a fully implantable total artificial heart that would eliminate the need for an external driver, potentially offering patients greater mobility compared to current systems. SynCardia selected Hydrix based on its experience in developing regulated medical devices and mechanical circulatory support systems.</p><p>Under the agreement, Hydrix will perform development work through the end of 2026 as an initial phase http://www.streetinsider.com/Corporate+News/Picard+Medical+partners+with+Hydrix+to+develop+next-gen+artificial+heart/25834966.html Mon, 12 Jan 2026 08:31:59 -0500 HYD PMI http://www.streetinsider.com/Corporate+News/Picard+Medical+partners+with+Hydrix+to+develop+next-gen+artificial+heart/25834966.html <p>Picard Medical Inc. (NYSE American: PMI) announced that its subsidiary SynCardia Systems entered into a development collaboration agreement with Hydrix Services Pty Ltd on January 5, 2026. The partnership aims to advance SynCardia's next-generation total artificial heart technology called the Emperor.</p><p>The Emperor represents a fully implantable total artificial heart that would eliminate the need for an external driver, potentially offering patients greater mobility compared to current systems. SynCardia selected Hydrix based on its experience in developing regulated medical devices and mechanical circulatory support systems.</p><p>Under the agreement, Hydrix will perform development work through the end of 2026 as an initial phase http://www.streetinsider.com/Corporate+News/Picard+Medical+partners+with+Hydrix+to+develop+next-gen+artificial+heart/25834966.html Mon, 12 Jan 2026 08:31:59 -0500 HYD PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Press+Releases/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html <p>TUCSON, Ariz., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that on January 5, 2026 SynCardia entered into a development collaboration agreement (the “Agreement”) with Hydrix Services Pty Ltd (“Hydrix”), a wholly owned subsidiary of Hydrix Limited (ASX: HYD), to commence an initial development phase for SynCardia’s next-generation, fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. As a fully implantable TAH, Emperor http://www.streetinsider.com/Globe+Newswire/SynCardia+and+Hydrix+Enter+into+Development+Collaboration+to+Advance+the+Emperor%2C+SynCardia%E2%80%99s+Next+Generation+Total+Artificial+Heart/25834925.html Mon, 12 Jan 2026 08:30:00 -0500 A.17150087 A.32418752 HYD O.00729880 O.03223113 O.21447847 O.49223070 PMI http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Press+Releases/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB http://www.streetinsider.com/Business+Wire/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html <p> NEW YORK--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vaneck.com%2Fus%2Fen%2F%3Futm_source%3Dpr%26utm_medium%3Dpressrelease&amp;esheet=53421954&amp;newsitemid=20230620941678&amp;lan=en-US&amp;anchor=VanEck&amp;index=1&amp;md5=c61e773d5f33e46ee23edc6db279f8d2" shape="rect">VanEck</a> today announced that it will be lowering the management fees on three of its Exchange Traded Funds (“ETFs”), as follows: </p><table cellspacing="0" class="bwblockalignl bwtablemarginb bwwidth75"> <tr> <td class="bwsinglebottom bwpadl0 bwwidth33 bwvertalignm" rowspan="1" colspan="1"><p class="bwcellpmargin"> <b>ETF Name</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth9 bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Ticker</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Current Management Fee</b> </p> </td> <td class="bwsinglebottom bwpadl0 bwwidth29 bwalignc bwvertalignm" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Reduced Management Fee</b> </p> </td> </tr> <tr> <td class="bwpadl0 bwwidth33" rowspan="1" colspan="1"><p class="bwcellpmargin"> VanEck Digital India ETF </p> </td> <td class="bwpadl0 bwwidth9" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> DGIN </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 bwalignc" rowspan="1" colspan="1"><p class="bwcellpmargin bwalignc"> 0.75% </p> </td> <td class="bwpadl0 bwpadr0 bwvertalignb bwwidth29 http://www.streetinsider.com/Business+Wire/VanEck+Lowers+Fees+For+Three+ETFs/21815727.html Tue, 20 Jun 2023 08:30:00 -0500 A.32483494 DGIN ESPO HYD O.28983715 SMB